Abbott Labarotories is buying CFR Pharmaceuticals of Peru for $2.9 billion announced on Friday afternoon in New York stock exchange
CFR Pharmaceuticals owns 49% of Allergy Therapeutics sharesI wonder if that has anything to do that shares went up on Friday afternoon
This user has not submitted any company ratings.
This user has not created any polls.